Inflammatory bowel disease: why this provides a useful example of the evolving science of nutrigenomics

References

• Baker PI, Love DR, Ferguson LR. 2009. Role of gut microbiota in Crohn’s disease. Expert Review of Gastroenterology & Hepatology. 3(5):535–546.
   PubMedGoogle Scholar
• Barnett M, Young W, Cooney J, Roy N. 2015. Metabolomics and proteomics, and what to do with all these ‘omes’: insights from nutrigenomic investigations in New Zealand. Journal of Nutrigenetics and Nutrigenomics. 7(4-6):274–282.
   Google Scholar
• Boss A, Kao CH, Murray PM, Marlow G, Barnett MP, Ferguson LR. 2016. Human intervention study to assess the effects of supplementation with olive leaf extract on peripheral blood mononuclear cell gene expression. International Journal of Molecular Sciences. 17(12):2019.
   Web of Science ®Google Scholar
• Browning BL, Annese V, Barclay ML, Bingham SA, Brand S, Buning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, et al. 2007a. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. Journal of Medical Genetics. 45(1):36–42.
   PubMed Web of Science ®Google Scholar
• Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. 2007b. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflammatory Bowel Diseases. 13(9):1069–1076.
   PubMed Web of Science ®Google Scholar
• Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. 2007c. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. The American Journal of Gastroenterology. 102(11):2504–2512.
   PubMed Web of Science ®Google Scholar
• Bush CL, Blumberg JB, El-Sohemy A, Minich DM, Jóse M, Ordovás JM, Reed DG, Behm VAY. 2020. Towards the definition of personalized nutrition: a proposal by the American Nutrition Association. Journal of the American College of Nutrition. 39(1):5–15.
   PubMed Web of Science ®Google Scholar
• Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, et al. 2016. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 387(10014):156–167.
   PubMed Web of Science ®Google Scholar
• Coppell KJ, Galts CP, Huizing FY, Norton JK, Gray AR, Schultz K, Hobbs CE, Aluzaite K, Schultz M. 2018. Annual incidence and phenotypic presentation of IBD in Southern New Zealand: An 18-year epidemiological analysis. Inflammatory Intestinal Diseases. 3(1):32–39.
   PubMedGoogle Scholar
• Eason RJ, Lee SP, Tasman-Jones C. 1982. Inflammatory bowel disease in Auckland, New Zealand. Australian and New Zealand Journal of Medicine. 12(2):125–131.
   PubMedGoogle Scholar
• Espley RV, Bovy A, Bava C, Jaeger SR, Tomes S, Norling C, Crawford J, Rowan D, McGhie TK, Brendolise C, et al. 2013. Analysis of genetically modified red-fleshed apples reveals effects on growth and consumer attributes. Plant Biotechnology Journal. 11(4):408–419.
   PubMed Web of Science ®Google Scholar
• Espley RV, Butts CA, Laing WA, Martell S, Smith H, McGhie TK, Zhang J, Paturi G, Hedderley D, Bovy A, et al. 2014. Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice. The Journal of Nutrition. 144(2):146–154.
   PubMed Web of Science ®Google Scholar
• Fenech M. 2000. The in vitro micronucleus technique. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 455:81–95.
   PubMed Web of Science ®Google Scholar
• Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TA, Tai ES, Milner J, Koh W-P, Xie L, Zucker M, et al. 2011. Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. Journal of Nutrigenetics and Nutrigenomics. 4(2):69–89.
   PubMedGoogle Scholar
• Ferguson LR. 2001. Role of plant polyphenols in genomic stability. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 475(1-2):89–111.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. 2010. Nutrigenomics and inflammatory bowel diseases. Expert Review of Clinical Immunology 6(4):573–583.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. 2012. Potential value of nutrigenomics in Crohn’s disease. Nature Reviews Gastroenterology & Hepatology 9(5):260–270.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. 2013. Nutrigenetics, nutrigenomics and inflammatory bowel diseases. Expert Review of Clinical Immunology. 9(8):717–726.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. 2015. Nutritional modulation of gene expression: might this be of benefit to individuals with Crohn’s disease? Frontiers in Immunology. 6:467.
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Barnett MP. 2016. Why are omics technologies important to understanding the role of nutrition in inflammatory bowel diseases? International Journal of Molecular Sciences. 17(10):E1763.
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Schlothauer RC. 2012. The potential role of nutritional genomics tools in validating high health foods for cancer control: broccoli as example. Molecular Nutrition & Food Research. 56(1):126–146.
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Smith BG, James BJ. 2010. Combining nutrition, food science and engineering in developing solutions to inflammatory bowel diseases–omega-3 polyunsaturated fatty acids as an example. Food & Function. 1(1):60–72.
   PubMed Web of Science ®Google Scholar
• Folkard DL, Marlow G, Mithen RF, Ferguson LR. 2015. Effect of sulforaphane on NOD2 via NF-κB: implications for Crohn’s disease. Journal of Inflammation. 12:6.
   Google Scholar
• Furey TS, Sethupathy P, Sheikh SZ. 2019. Redefining the IBDs using genome-scale molecular phenotyping. Nature Reviews Gastroenterology & Hepatology. 16(5):296–231.
   PubMed Web of Science ®Google Scholar
• Gassull MA, Cabré E. 2001. Nutrition in inflammatory bowel disease. Current Opinion in Clinical Nutrition and Metabolic Care. 4:561–569.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. 2010. Population-based cases control study of inflammatory bowel disease risk factors. Journal of Gastroenterology and Hepatology. 25(2):325–333.
   PubMed Web of Science ®Google Scholar
• Gentschew L, Ferguson LR. 2012. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Molecular Nutrition & Food Research. 56(4):524–535.
   PubMed Web of Science ®Google Scholar
• Grimaldi KA, van Ommen B, Ordovas JM, Parnell LD, Mathers JC, Bendik I, Brennan L, Celis-Morales C, Cirillo E, Daniel H, et al. 2017. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes & Nutrition. 12:35.
   PubMed Web of Science ®Google Scholar
• Han DY, Fraser AG, Dryland P, Ferguson LR. 2010. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn’s disease within New Zealand. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690(1-2):116–122.
   PubMed Web of Science ®Google Scholar
• Harries A, Rhodes J. 1985. Undernutrition in Crohn’s disease: an anthropometric assessment. Clinical Nutrition. 4:87–89.
   PubMed Web of Science ®Google Scholar
• Huebner C, Ding Y, Petermann I, Knapp C, Ferguson LR. 2011. The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn’s disease-associated E. coli LF82. Applied and Environmental Microbiology. 77(7):2541–2544.
   PubMed Web of Science ®Google Scholar
• Huebner C, Petermann I, Lam WJ, Shelling AN, Ferguson LR. 2010. Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. Inflammatory Bowel Diseases. 16(2):282–295.
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard J-P, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 411(6837):599–603.
   PubMed Web of Science ®Google Scholar
• Ikram MK, Xueling S, Jensen RA, Cotch MF, Hewitt AW, Ikram MA, Wang JJ, Klein R, Klein BEK, Breteler MMB, et al. 2010. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genetics. 6:e1001184.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Philip Schumm L, Sharma Y, Anderson CA, et al. 2012. Host-microbe interactions have shaped the genetic architecture of infammatory bowel disease. Nature. 491:119–124.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. 2015. The global burden of IBD: from 2015 to 2025. Nature Reviews Gastroenterology & Hepatology. 12(12):720–727.
   PubMed Web of Science ®Google Scholar
• Kaput J, Ordovas JM, Ferguson L, van Ommen B, Rodriguez RL, Allen L, Ames BN, Dawson K, German B, Krauss R, et al. 2005. The case for strategic international alliances to harness nutritional genomics for public and personal health. British Journal of Nutrition. 94(5):623–632.
   PubMed Web of Science ®Google Scholar
• Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, et al. 2004. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Human Molecular Genetics. 13(1):35–45.
   PubMed Web of Science ®Google Scholar
• Kohlmeier M, De Caterina R, Ferguson LR, Görman U, Allayee H, Prasad C, Kang JX, Nicoletti CF, Martinez JA. 2016. Guide and position of the international society of nutrigenetics/nutrigenomics on personalized nutrition: part 2 – ethics, challenges and endeavours of precision nutrition. Journal of Nutrigenetics and Nutrigenomics. 9(1):28–46.
   PubMed Web of Science ®Google Scholar
• Laing B, Barnett MPG, Marlow G, Nasef NA, Ferguson LR. 2018. An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Review of Gastroenterology & Hepatology. 12(10):969–983.
   PubMed Web of Science ®Google Scholar
• Laing B, Han DY, Ferguson LR. 2013. Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn’s disease cohort. Nutrients. 5(12):5046–5064.
   PubMed Web of Science ®Google Scholar
• Laing BB, Lim AG, Ferguson LR. 2019. A personalised dietary approach—a way forward to manage nutrient deficiency, effects of the western diet, and food intolerances in inflammatory bowel disease. Nutrients. 11(7):E1532.
   PubMed Web of Science ®Google Scholar
• Lee HS, Cleynen I. 2019. Molecular profiling of inflammatory bowel disease: is it ready for use in clinical decision-making? Cells. 8(6):E535–E554.
   PubMed Web of Science ®Google Scholar
• Lim CC, Ferguson LR, Tannock GW. 2005. Dietary fibres as “prebiotics”: implications for colorectal cancer. Molecular Nutrition & Food Research. 49(6):609–619.
   PubMed Web of Science ®Google Scholar
• Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, Helsby NA, Ferguson LR, Rowan DD. 2010. Metabolomic analysis identifies inflammatory and non-inflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. Journal of Proteome Research. 9(4):1965–1975.
   PubMed Web of Science ®Google Scholar
• Lin HM, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD. 2009. Non-targeted urinary metabolite profiling of a mouse model of Crohn’s disease. Journal of Proteome Research. 8(4):2045–2057.
   PubMed Web of Science ®Google Scholar
• Lin HM, Edmunds SJ, Zhu S, Helsby NA, Ferguson LR, Rowan DD. 2011a. Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease. Molecular Nutrition & Food Research. 55(12):1900–1904.
   PubMed Web of Science ®Google Scholar
• Lin HM, Helsby NA, Rowan DD, Ferguson LR. 2011b. Using metabolomic analysis to understand inflammatory bowel diseases. Inflammatory Bowel Diseases. 17(4):1021–1029.
   PubMed Web of Science ®Google Scholar
• Low JH, Williams FA, Yang X, Cullen S, Colley J, Ling KL, Armuzzi A, Ahmad T, Neville MJ, Dechairo BM, et al. 2004. Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflammatory Bowel Diseases. 10(3):173–181.
   PubMed Web of Science ®Google Scholar
• Marlow GJ, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC, Han D, Fraser AG, Ferguson LR. 2013a. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn’s disease patients. Human Genomics. 7:24.
   PubMed Web of Science ®Google Scholar
• Marlow GJ, Han DY, Triggs CM, Ferguson LR. 2015a. Food intolerance: associations with the rs12212067 polymorphism of FOXO3 in Crohn’s disease patients in New Zealand. Journal of Nutrigenetics and Nutrigenomics. 8(2):70–80.
   PubMedGoogle Scholar
• Marlow GJ, Han DY, Wickens K, Stanley T, Crane J, Mitchell EA, Dekker J, Barthow C, Fitzharris P, Ferguson LR, et al. 2015b. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatric Allergy and Immunology. 26(3):262–271.
   PubMed Web of Science ®Google Scholar
• Marlow GJ, van Gent D, Ferguson LR. 2013b. Why interleukin-10 supplementation does not work in Crohn's disease patients. World Journal of Gastroenterology. 19(25):3931–3941. doi:10.3748/wjg.v19.i25.3931.
   PubMed Web of Science ®Google Scholar
• Mathew CG, Lewis CM. 2004. Genetics of inflammatory bowel disease: progress and prospects. Human Molecular Genetics. 13(90001):161R–1168.
   Google Scholar
• Momozawa Y, Dmitrieva J, Théâtre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori A-S, et al. 2018. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications. 9(1):2427.
   PubMedGoogle Scholar
• Nasef NA, Mehta S, Ferguson LR. 2014a. Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case. Frontiers in Genetics. 5:64.
   PubMed Web of Science ®Google Scholar
• Nasef NA, Mehta S, Murray P, Marlow GJ, Ferguson LR. 2014b. Anti-inflammatory activity of fruit fractions in vitro, mediated through toll-like receptor 4 and 2 in the context of inflammatory bowel disease. Nutrients. 6(11):5265–5279.
   PubMed Web of Science ®Google Scholar
• Nasef NA, Mehta S, Powell P, Marlow G, Wileman T, Ferguson LR, Ojcius DM. 2015. Extracts of feijoa inhibit toll-like receptor 2 signaling and activate autophagy implicating a role in dietary control of IBD. PLoS One. 10(6):e0130910.
   PubMed Web of Science ®Google Scholar
• Nasir A, Bullo MMH, Ahmed Z, Imtiaz A, Yaqoob E, Jadoon M, Ahmed H, Afreen A, Yaqoob S. 2019. Nutrigenomics: epigenetics and cancer prevention: a comprehensive review. Critical Reviews in Food Science and Nutrition. 59:1–13.
   PubMedGoogle Scholar
• Nolan-Clark D, Tapsell LC, Hu R, Han DY, Ferguson LR. 2011. Effects of dairy products on Crohn’s disease symptoms are influenced by fat content and disease location but not lactose content or disease activity status in a New Zealand population. Journal of the American Dietetic Association. 111(8):1165–1172.
   PubMedGoogle Scholar
• Nolan DJ, Han DY, Lam WJ, Morgan AR, Fraser AG, Tapsell LC, Ferguson LR. 2010. Genetic adult lactase persistence is associated with risk of Crohn’s disease in a New Zealand population. BMC Research Notes. 3:339.
   PubMedGoogle Scholar
• Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei S-C, et al. 2016a. Asia Pacific consensus statements on Crohn’s disease. part 1: definition, diagnosis, and epidemiology. Journal of Gastroenterology and Hepatology. 31(1):45–55.
   PubMed Web of Science ®Google Scholar
• Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei S-C, et al. 2016b. Asia-Pacific consensus statements on Crohn’s disease. Part 2: management. Journal of Gastroenterology and Hepatology. 31(1):56–68.
   PubMed Web of Science ®Google Scholar
• Orchard TR, Satsangi J, Van Heel D, Jewell DP. 2000. Genetics of inflammatory bowel disease: a reappraisal. Scandinavian Journal of Immunology. 51(1):10–17.
   PubMed Web of Science ®Google Scholar
• Peña-Romero AC, Navas-Carrillo D, Marín F, Orenes-Piñero E. 2018. The future of nutrition: nutrigenomics and nutrigenetics in obesity and cardiovascular diseases. Critical Reviews in Food Science and Nutrition. 58(17):3030–3041.
   PubMed Web of Science ®Google Scholar
• Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, et al. 2009a. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Human Immunology. 70(6):440–446.
   PubMed Web of Science ®Google Scholar
• Petermann I, Triggs CM, Huebner C, Han DY, Gearry RB, Barclay ML, Demmers PS, McCulloch A, Ferguson LR. 2009b. Mushroom intolerance: a novel diet-gene interaction in Crohn’s disease. British Journal of Nutrition. 102(4):506–508.
   PubMed Web of Science ®Google Scholar
• Philpott M, Mackay L, Ferguson LR, Forbes D, Skinner M. 2007. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 622(1-2):94–102.
   PubMed Web of Science ®Google Scholar
• Plichta DR, Graham DB, Subramanian S, Xavier RJ. 2019. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships. Cell. 178(5):1041–1056.
   PubMed Web of Science ®Google Scholar
• Rhodes J, Rose J. 1986. Does food affect acute inflammatory bowel disease? The role of parenteral nutrition, elemental and exclusion diets. Gut. 27(5):471–474.
   PubMed Web of Science ®Google Scholar
• Rockman MV, Kruglyak L. 2006. Genetics of global gene expression. Nature Reviews Genetics. 7(11):862–872.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Jewell DP, Rosenberg WM, Bell JI. 1994. Genetics of inflammatory bowel disease. Gut. 35(5):696–700.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, Clombel JF. 2006. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 55:749–753.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP. 1996. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 347(9010):1212–1217.
   PubMed Web of Science ®Google Scholar
• Singer HC, Anderson JG, Frischer H, Kirsner JB. 1971. Familial aspects of inflammatory bowel disease. Gastroenterology. 61(4):423–430.
   PubMed Web of Science ®Google Scholar
• Sun-Waterhouse D, Chen J, Chuah C, Wibisono R, Melton LD, Laing W, Ferguson LR, Skinner MA. 2009. Kiwifruit-based polyphenols and related antioxidants for functional foods: kiwifruit extract-enhanced gluten-free bread. International Journal of Food Sciences and Nutrition. 60(Suppl 7):251–264.
   PubMedGoogle Scholar
• Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR. 2010. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn’s disease population. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 690(1-2):123–138.
   PubMed Web of Science ®Google Scholar
• van Ommen B, Stierum R. 2002. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Current Opinion in Biotechnology. 13(5):517–521.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. 2001. Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. Gastroenterology. 120(4):834–840.
   PubMed Web of Science ®Google Scholar
• Wong C, Harris PJ, Ferguson LR. 2016. Potential benefits of dietary fibre intervention in inflammatory bowel disease. International Journal of Molecular Sciences. 17(6): 919.
   Web of Science ®Google Scholar
• Zhang JD, Küng E, Boess F, Certa U, Ebeling M. 2015. Pathway reporter genes define molecular phenotypes of human cells. BMC Genomics. 16:342.
   PubMed Web of Science ®Google Scholar